SIGA Technologies Inc
Research SIGA Technologies Inc (SIGA) on Bullrun: market cap USD 218.41M, dividend yield 19.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSIGA
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 218.41M
- Dividend yield19.6%
- Financial periodQ2 2026
- RevenueUSD 41.00M
- Net incomeUSD 12.46M
- Free cash flowUSD 15.17M
- Gross margin57.2%
Valuation Snapshot
latest market cap is USD 218.41M; dividend yield is 19.6%.
Peer valuation comparison
Latest dividend yield is 19.61% versus a Healthcare sector median of 2.11% (829.4% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 94.57M | USD 23.28M | USD 43.12M | 68.6% | 0.32 | USD 154.97M | USD 595.17K | USD 198.82M |
| FY2024 | USD 138.72M | USD 59.21M | USD 48.72M | 77.4% | 0.82 | USD 155.40M | USD 546.82K | USD 215.80M |
| FY2023 | USD 139.92M | USD 68.07M | n/a | 87.3% | 0.95 | USD 150.15M | USD 564.01K | USD 196.86M |
| FY2022 | USD 110.78M | USD 33.90M | n/a | 90.6% | 0.46 | USD 98.79M | USD 507.14K | USD 170.16M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 218.41M | n/a | 19.7% | 0.6 |
| 2025 | 2025-12-31 | USD 437.55M | 19.1 | 9.8% | 0.6 |
| 2024 | 2024-12-31 | USD 429.14M | 7.2 | 10.0% | 0.6 |
| 2023 | 2023-12-29 | USD 398.11M | n/a | 8.0% | 0.45 |
| 2022 | 2022-12-30 | USD 537.46M | 5.1 | 6.1% | 0.45 |
| 2021 | 2021-12-31 | USD 553.05M | 8.2 | n/a | n/a |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 USD, yield 19.6%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.6 USD |
| FY2024 | 0.6 USD |
| FY2023 | 0.45 USD |
| FY2022 | 0.45 USD |
About SIGA Technologies Inc
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SIGA Technologies Inc's market cap?
SIGA Technologies Inc's market capitalization is USD 218.41M.
Does SIGA Technologies Inc pay a dividend?
SIGA Technologies Inc has a dividend yield of 19.6%.
What does SIGA Technologies Inc do?
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.